U.S. Household Products Stock News

RadNet, Inc. has reported its fourth-quarter 2025 results, with revenue rising to US$547.71 million while swinging from a US$5.35 million profit to a US$0.60 million net loss, and full-year revenue increasing to US$2.04 billions alongside a move from a US$2.79 million profit to a US$18.65 million loss. This combination of higher sales but losses at both the quarterly and annual level raises questions about the near-term payoff of RadNet’s investment and cost structure decisions. We’ll now...

In February 2026, Alarm.com Holdings reported fourth-quarter 2025 revenue of US$261.66 million and net income of US$34.73 million, alongside full-year 2025 revenue of US$1.01 billion and net income of US$132.57 million, and issued new 2026 revenue guidance. Management also signaled plans to prioritize high-return organic investments and selective acquisitions, indicating an active approach to reinforcing its competitive position and expanding its platform. We’ll now examine how Alarm.com’s...

Cimpress recently reported past second quarter fiscal 2026 results with adjusted earnings per share of US$1.95, above estimates but lower year over year, alongside 11% revenue growth driven by all business units. The company also lifted its full-year revenue growth outlook to 7–8% and projected at least US$460,000,000 in adjusted EBITDA, signaling confidence in its operating trajectory. We’ll now examine how Cimpress’s raised full-year revenue guidance reshapes the company’s investment...

In late February 2026, BioCryst Pharmaceuticals reported fourth-quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, capping its first full year of profitability with US$874.84 million in revenue and US$263.86 million in net income. The move into sustained profitability, underpinned by strong ORLADEYO performance and the Astria Therapeutics acquisition that broadened its hereditary angioedema portfolio, marks a step-change in BioCryst’s financial and competitive...

In late February 2026, Coursera reported quarterly results showing stronger consumer segment performance alongside a softer enterprise environment, and issued revenue growth guidance for 2026 that was above prior market expectations. The combination of outperformance in consumer learning and a more upbeat revenue outlook, despite enterprise softness, has sharpened investor focus on how Coursera balances its two core segments. Now we’ll assess how Coursera’s above-consensus 2026 revenue...

In February 2026, Rackspace Technology reported fourth quarter 2025 revenue of US$682.8 million and a net loss of US$32.7 million, alongside full-year 2025 revenue of US$2.69 billion and a net loss of US$225.8 million, both narrower than the prior year. The company also issued 2026 revenue guidance of US$2.60 billion to US$2.70 billion, giving investors a clearer view of expected top-line stability while losses remain material. Next, we will examine how Rackspace’s narrower 2025 net loss and...

Pediatrix Medical Group (MD) has drawn investor attention after recent share performance, with the stock down about 7% over the past month and 17% over the past 3 months, despite positive 1 year and 3 year total returns. See our latest analysis for Pediatrix Medical Group. The recent 7% 1 month and 17% 3 month share price declines suggest fading near term momentum, even though the 1 year and 3 year total shareholder returns remain positive. This can reflect investors reassessing Pediatrix...

Houlihan Lokey filed an SEC prospectus supplement covering the resale of new Class A shares tied to recent acquisitions and performance milestones. The filing sets out how these newly issued shares can be resold by certain holders, clarifying the legal status of stock linked to completed deals. The move sheds light on how Houlihan Lokey structures equity based incentives for acquired teams and deal related performance. For you as an investor looking at NYSE:HLI, this filing provides an...

Belite Bio (BLTE) shares are under the spotlight after the company reported a fourth quarter net loss of US$25.32 million and a full year net loss of US$77.61 million, both above prior-year levels. See our latest analysis for Belite Bio. Despite the wider losses, Belite Bio’s share price has shown strong momentum, with a 26.16% 90 day share price return and a very large 1 year total shareholder return that sits near 5x. This may point to shifting expectations around its pipeline rather than...

What USA Compression Partners stock’s recent performance suggests USA Compression Partners (USAC) has drawn investor interest after a period where the unit price showed a 1 day decline of about 1%, set against positive returns over the past month and the past 3 months. See our latest analysis for USA Compression Partners. That small 1 day share price pullback sits against a 30 day share price return of 5.65% and a 90 day gain of 10.97%, while the 5 year total shareholder return of 212.85%...

Lineage (LINE) is back in focus after reporting fourth quarter and full year 2025 results, which included a swing to a Q4 profit and a sharply smaller annual net loss, catching investors’ attention. See our latest analysis for Lineage. At a share price of US$40.52, Lineage has seen a 5.8% 7 day share price return, a 13.5% 30 day share price return, and a 14.4% year to date share price return. However, its 1 year total shareholder return of a 29.3% decline shows that recent momentum is...

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...

Ryder System recently reported fourth-quarter 2025 results that exceeded expectations and paired them with an upbeat earnings outlook for 2026, highlighting resilient performance across its logistics and vehicle services operations. This strong update comes shortly after sizable insider share sales by senior executives, drawing attention to how leadership actions align with Ryder’s growth and capital allocation plans. With Ryder’s better-than-expected quarter and optimistic 2026 guidance now...

Preferred Bank (PFBC) has drawn fresh attention after recent trading left the stock around $87.72. Mixed returns over the past week, month and past 3 months are prompting investors to reassess its current valuation. See our latest analysis for Preferred Bank. The recent 1 day share price decline of 3.36% and year to date share price return of negative 8.57% contrast with a 1 year total shareholder return of 3.12%. This suggests shorter term momentum has cooled even as longer term holders have...

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...

Astec Industries, Inc. has now reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$400.6 million from US$359.0 million and full-year sales reaching US$1.41 billion, while net income increased to US$38.8 million for 2025 and the Board maintained a quarterly dividend of US$0.13 per share payable in March 2026. Despite Q4 net income easing year on year, the company delivered record quarterly and annual sales, beat analyst earnings and revenue expectations,...

IMAX Corporation recently reported fourth-quarter 2025 revenue of US$125.21 million and full-year 2025 revenue of US$410.21 million, with annual net income rising to US$34.88 million even as quarterly net income softened. The company paired these record box office and revenue results with ongoing global network expansion and deeper local-language and live-event content partnerships, including a new collaboration with Apple TV to screen select 2026 Formula One races in IMAX theaters. We’ll...

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...

In February 2026, The Allstate Corporation declared approximately US$29.3 million in cash dividends on its Series H, I and J preferred stock for the January 15 to April 14 period, payable on April 15 to stockholders of record on March 31, alongside board approval of a higher quarterly common dividend of US$1.08 per share. This combination of stronger earnings, improved auto and homeowners loss ratios, and increased common and preferred dividends underlines management’s confidence in the...

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...

Why Terreno Realty is on investors’ radar today Terreno Realty (TRNO) is drawing fresh attention after recent price moves, with the stock last closing at US$66.06 and showing mixed returns over the past month and past 3 months. See our latest analysis for Terreno Realty. Terreno Realty’s recent move to US$66.06 comes alongside a 7.34% 1 month share price return and an 11.93% year to date share price return. Its 5 year total shareholder return of 36.75% points to steadier long term...